All Employment articles
View all stories with this category.
-
BusinessPfizer to close two manufacturing plants in India
Closures will lead to the loss of 1700 jobs – almost 6% of the pharma giant’s manufacturing workforce
-
Business
Novartis to cut over 2000 jobs
Move exemplifies a wave of manufacturing cuts as pharma moves to more high-value, specialised medicines
-
Business
Novartis exit from antibiotics a setback for race against resistance
Experts say business models must change to halt big pharma exodus
-
News
Apotex chief executive steps down amid tumult at generics firm
President and chief executive of Canada’s biggest generic drugmaker resigns the same day that police announce its founder and his wife were murdered
-
Business
Dementia slips down pharma agenda
Pfizer, Shire, Acorda and Axovant rethink their neuroscience strategies
-
Business
Teva to cut 14,000 jobs
Saddled with debt in an increasingly competitive generic drug industry, the Israel-headquartered giant begins a difficult transformation
-
Business
Pharmaceuticals roundup 2017
Political influence has strongly shaped industry activity in the past year
-
Business
Merck & Co and Qiagen to build UK research hubs
Almost 2000 jobs to be created at research centres in Manchester and London
-
Business
European drug regulator heads to Amsterdam
Brexit drives EMA to relocate, taking hundreds of jobs and significant expertise away from UK
-
Business
Russia backs new research cluster
Government touts high-tech science area as Russia’s answer to Silicon Valley
-
Business
Alexion axes 20% of its global workforce
600 jobs lost amid restructure as firm moves to Boston life sciences hub
-
Business
Eli Lilly to cut 3500 jobs
Company will close sites in US and China, and provide incentives for early retirement
-
Business
Israeli company Haifa Chemicals shuttered
Lack of ammonia storage facility leads to colossal losses
-
Business
Midwest Fertilizer to build $2.8bn manufacturing plant
Domestic facility will reduce imports
-
Business
LyondellBasell to build world’s largest propylene oxide plant
Petrochemical giant gets go-ahead for most expensive project to date
-
News
Spain loses 12,000 researchers in five years
Falling R&D investment is leading to a ‘brain drain’
-
Business
How do chemical firms last hundreds of years?
What distinguishes companies that thrive from others that failed?
-
Business
Job cuts at Amgen, Takeda and Vertex
Takeda reorganising following Ariad takeover, while Amgen and Vertex move staff to Cambridge and San Francisco hubs
-
Business
J&J to close Scottish medical device plant
Up to 400 positions affected as Ethicon subsidiary leaves Livingston
-
Business
Daiichi Sankyo to close R&D sites in India and Japan
Closures are part of an ongoing reorganisation aimed at increasing productivity
